Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 2
Author(s): Ferdinando Nicoletti
Affiliation:
Export Options
About this article
Cite this article as:
Nicoletti Ferdinando , Meet Our Editorial Board Member, Current Neuropharmacology 2018; 16 (2) . https://dx.doi.org/10.2174/1570159X1602180130155228
DOI https://dx.doi.org/10.2174/1570159X1602180130155228 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
28
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities
Current Pharmaceutical Biotechnology Neuronal Nicotinic Acetylcholine Receptors as Pharmacotherapeutic Targets for the Treatment of Alcohol Use Disorders
CNS & Neurological Disorders - Drug Targets Matrix Factorization-based Improved Classification of Gene Expression Data
Recent Advances in Computer Science and Communications Postoperative Radiotherapy After Radical Prostatectomy: Adjuvant or Salvage?
Current Cancer Therapy Reviews Urine Comprehensive Drug Screen, Low Birth Weight and Withdrawal Symptoms in a Neonatal Unit: A Case Control Study
Current Clinical Pharmacology Relapse Prevention
Adolescent Psychiatry Dopamine and the Diseased Brain
CNS & Neurological Disorders - Drug Targets Pharmacological Characteristics of Parenteral IGF-I Administration
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: Immunologic Mechanisms in Neurological Diseases)
Current Immunology Reviews (Discontinued) Desferrioxamine as Immunomodulatory Agent During Microorganism Infection
Current Pharmaceutical Design Interferon alpha for Treatment of Chronic Myeloid Leukemia
Current Drug Targets Exome-wide pharmacogenomic analysis of response to thiopurines in inflammatory bowel disease patients
Current Pharmacogenomics and Personalized Medicine Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders
Current Pharmaceutical Design Vascular Changes of the Retina and Choroid in Systemic Lupus Erythematosus: Pathology and Pathogenesis
Current Neurovascular Research Appraisal of Anti-Arthritic and Anti-Inflammatory Potential of Folkloric Medicinal Plant <i>Peganum harmala</i>
Endocrine, Metabolic & Immune Disorders - Drug Targets Isoniazid: Metabolic Aspects and Toxicological Correlates
Current Drug Metabolism Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects
Current Cancer Drug Targets Presynaptic NR2B-Containing NMDA Autoreceptors Mediate Glutamatergic Synaptic Transmission in the Rat Visual Cortex
Current Neurovascular Research Natural Anti-Cancer Agents: Implications in Gemcitabine-Resistant Pancreatic Cancer Treatment
Mini-Reviews in Medicinal Chemistry Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
Current Neuropharmacology